MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms.
Soldevilla B, Lens-Pardo A, Espinosa-Olarte P, Carretero-Puche C, Molina-Pinelo S, Robles C, Benavent M, Gomez-Izquierdo L, Fierro-Fernández M, Morales-Burgo P, Jimenez-Fonseca P, Anton-Pascual B, Rodriguez-Gil Y, Teijo-Quintans A, La Salvia A, Rubio-Cuesta B, Riesco-Martínez MC, Garcia-Carbonero R.
Soldevilla B, et al. Among authors: teijo quintans a.
Mol Oncol. 2023 Apr;17(4):582-597. doi: 10.1002/1878-0261.13393. Epub 2023 Mar 5.
Mol Oncol. 2023.
PMID: 36795001
Free PMC article.